LRINEC Score Calculator — Necrotizing Fasciitis Risk Assessment
The Laboratory Risk Indicator for Necrotizing Fasciitis (LRINEC) score is a clinically validated scoring system used to distinguish necrotizing fasciitis from other severe soft tissue infections. It uses six routine laboratory parameters to stratify patients into low, moderate, or high risk for necrotizing fasciitis, aiding in early surgical decision-making.
About
The LRINEC score was developed by Wong et al. in 2004 based on a retrospective review of 89 patients with necrotizing fasciitis and 225 control patients with severe cellulitis or abscesses. The score assigns points to six routine laboratory parameters: C-reactive protein (CRP), white blood cell count (WBC), hemoglobin, serum sodium, serum creatinine, and serum glucose. The maximum score is 13, with higher scores indicating greater risk of necrotizing fasciitis. The score has been externally validated in multiple studies with good discriminatory power (area under the curve 0.80-0.96), though clinical judgment remains paramount as the score has limited sensitivity in certain populations (e.g., immunocompromised patients, early presentations).
Formula
LRINEC = CRP (≥150 = 4 pts) + WBC (15-25 = 1, >25 = 2 pts) + Hemoglobin (11-13.5 = 1, <11 = 2 pts) + Sodium (<135 = 2 pts) + Creatinine (>1.6 = 2 pts) + Glucose (>180 = 1 pt)
The LRINEC score is calculated by summing points from six laboratory parameters. CRP: <150 mg/L = 0, ≥150 = 4 points. WBC: <15 ×10³/µL = 0, 15-25 = 1, >25 = 2 points. Hemoglobin: >13.5 g/dL = 0, 11-13.5 = 1, <11 = 2 points. Sodium: ≥135 mmol/L = 0, <135 = 2 points. Creatinine: ≤1.6 mg/dL = 0, >1.6 = 2 points. Glucose: ≤180 mg/dL = 0, >180 = 1 point. Total score (0-13) stratifies risk: 0-5 low risk (<50% NF), 6-7 moderate risk (50-75% NF), 8-13 high risk (>75% NF). Important: The LRINEC score is a diagnostic adjunct and should not replace clinical suspicion. A high clinical suspicion for necrotizing fasciitis warrants surgical exploration regardless of LRINEC score. The score performs less well in immunocompromised patients, diabetics, and patients with early presentations (<24 hours of symptoms).
Score Interpretation
The LRINEC score addresses a critical diagnostic challenge in emergency medicine and surgery: the early differentiation of necrotizing fasciitis from severe cellulitis or abscess. Necrotizing fasciitis is a life-threatening surgical emergency with mortality rates of 25-35%, and delays in surgical intervention beyond 12-24 hours significantly increase mortality. The LRINEC score provides objective laboratory criteria that can raise suspicion for NF and prompt earlier surgical consultation. However, clinicians must be aware of its limitations: a low LRINEC score does not rule out NF (false negative rate ~10-20%), and the score has reduced sensitivity in immunocompromised patients, those with diabetes, and in very early presentations. The score is most useful as a "rule-in" tool rather than a "rule-out" tool, and clinical judgment remains the most important factor in the diagnosis of necrotizing fasciitis.
Low Risk (<50% NF) — 0–5
LRINEC 0-5. Low risk of necrotizing fasciitis.
Management: Necrotizing fasciitis unlikely. Monitor clinically. Consider alternative diagnoses.
Moderate Risk (50-75% NF) — 6–7
LRINEC 6-7. Moderate risk of necrotizing fasciitis.
Management: Urgent surgical consultation for exploration. Start empiric broad-spectrum antibiotics.
High Risk (>75% NF) — 8–13
LRINEC 8-13. High risk of necrotizing fasciitis.
Management: Emergency surgical exploration and debridement. Aggressive resuscitation and ICU care.
Reference Ranges
| Population | Normal Range | Notes |
|---|---|---|
| Suspected soft tissue infection | 0-13 points (Low: 0-5, Moderate: 6-7, High: 8-13) | Higher score = higher risk of NF. Score does not rule out NF; clinical judgment is paramount. |
Dr. Mahmoud El-Sayed
Dr. Mahmoud is an endocrinology consultant with expertise in metabolic and infectious disease assessment.
View medical review board & editorial policy →Example Calculation
A 58-year-old diabetic man presents with severe right lower extremity pain, swelling, and erythema with systemic toxicity. Temperature 39.2°C, HR 112, BP 95/60. Labs: CRP 220 mg/L (≥150 = 4 pts), WBC 28 ×10³/µL (>25 = 2 pts), Hemoglobin 10.2 g/dL (<11 = 2 pts), Sodium 131 mmol/L (<135 = 2 pts), Creatinine 2.1 mg/dL (>1.6 = 2 pts), Glucose 240 mg/dL (>180 = 1 pt). Total LRINEC = 4 + 2 + 2 + 2 + 2 + 1 = 13 — High risk (>75% NF). The patient underwent emergency surgical exploration which confirmed necrotizing fasciitis, requiring extensive debridement. He was admitted to ICU postoperatively and recovered after multiple debridement sessions and prolonged antibiotic therapy.
Related Conditions
Related Medications
Common Mistakes
Using LRINEC to rule out necrotizing fasciitis
LRINEC has limited sensitivity (~68-90%). A low score does NOT rule out NF. Clinical suspicion should prompt surgical exploration regardless of score.
Relying on LRINEC in immunocompromised patients
The LRINEC score has reduced sensitivity in immunocompromised, diabetic, and elderly populations. Clinical judgment is especially important in these groups.
Delaying surgical consultation while waiting for all lab results
If clinical suspicion is high, initiate surgical consultation immediately. LRINEC is an adjunct, not a prerequisite for surgical evaluation.
Frequently Asked Questions
Can LRINEC rule out necrotizing fasciitis?
What is the highest LRINEC score possible?
Is LRINEC validated for pediatric patients?
References
- Wong CH, Khin LW, Heng KS, et al. The LRINEC (Laboratory Risk Indicator for Necrotizing Fasciitis) score: a tool for distinguishing necrotizing fasciitis from other soft tissue infections. Crit Care Med. 2004;32(7):1535-1541. PubMed
- Borschitz T, Schlicht S, Siegel E, et al. Improvement of a clinical score for necrotizing fasciitis: "pain out of proportion" and high CRP levels aid the diagnosis. PLoS One. 2015;10(7):e0132775. PubMed
- Su YC, Chen HW, Hong YC, et al. Laboratory risk indicator for necrotizing fasciitis score and the outcomes. ANZ J Surg. 2008;78(11):968-972. PubMed
- Stevens DL, Bisno AL, Chambers HF, et al. Practice guidelines for the diagnosis and management of skin and soft tissue infections: 2014 update by the IDSA. Clin Infect Dis. 2014;59(2):e10-52. PubMed